Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer
Colorectal cancer screening by fecal immunochemical test (FIT) reduces the burden of colorectal cancer. However, effectiveness relies on annual adherence, which presents challenges for clinic staff and patients.
Describe FIT return rates and identify factors associated with FIT adherence over 2 years in a mailed FIT outreach program in federally qualified health centers.
Observational study nested in the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (STOP CRC) trial. Five thousand one hundred ninety-five patients had an initial FIT order and were followed for ≥ 2 years (3574 also had a FIT order in the second year).
FIT return percent in each year and patient- and neighborhood-level characteristics associated with FIT adherence.
Overall, the proportion of FIT orders that were completed was 46% in the patients’ first year and 41% in the patients’ second year. Of the 5195 patients with a FIT order in year 1, 3574 (69%) also had a FIT order in year 2 (71% of year 1 adherers and 67% of year 1 non-adherers, p = 0.009). Among those with a FIT order in the second year, the FIT return rate was about twice as high among those who were adherent in the first year (952/1674, or 57%) as among those who were not (531/1900, or 28%, p < 0.0001). Patient-level characteristics associated with higher odds of FIT return were a history of FIT screening at baseline, age over 65 (vs 50–65), no current tobacco use, recent receipt of a mammogram or flu vaccine, Asian ancestry (compared to non-Hispanic white), and non-English preference. The only neighborhood factor associated with lower FIT return rate was patient’s larger residential city size.
Our findings can inform the customization of programs to promote FIT return among patients who receive care at federally qualified health centers.
KEY WORDScolorectal cancer fecal immunochemical test screening
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number UH3CA188640.
Compliance with Ethical Standards
Conflict of Interest
Dr. Coronado served as a co-investigator on a study funded by Epigenomics and as a principal investigator on a study funded by Quidel Corporation. The studies had no influence on the design, conduct, or reporting of the present study. All remaining authors declare that they do not have a conflict of interest.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study sponsor had no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.
- 1.Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA. Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening. Clin Gastroenterol Hepatol. 2017;15(6):903–9 e6. https://doi.org/10.1016/j.cgh.2016.08.037 CrossRefPubMedGoogle Scholar
- 4.Breen N, Lewis DR, Gibson JT, Yu M, Harper S. Assessing disparities in colorectal cancer mortality by socioeconomic status using new tools: health disparities calculator and socioeconomic quintiles. Cancer Causes Control. 2017;28(2):117–25. https://doi.org/10.1007/s10552-016-0842-2 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725–32. https://doi.org/10.1001/jamainternmed.2013.9294 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Davis SN, Christy SM, Chavarria EA, Abdulla R, Sutton SK, Schmidt AR, et al. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer. 2017;123(8):1390–400. https://doi.org/10.1002/cncr.30481 CrossRefPubMedGoogle Scholar
- 10.Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–76. https://doi.org/10.7326/0003-4819-152-10-201005180-00239 CrossRefPubMedGoogle Scholar
- 13.Denters MJ, Deutekom M, Bossuyt PM, van Rijn AF, Fockens P, Dekker E. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening. Cancer Epidemiol. 2013;37(3):330–5. https://doi.org/10.1016/j.canep.2013.01.007 CrossRefPubMedGoogle Scholar
- 18.Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, et al. Patterns and predictors or repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018. https://doi.org/10.1038/s41395-018-0023-x
- 22.Baker DW, Brown T, Goldman SN, Liss DT, Kollar S, Balsley K, et al. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers. Cancer Causes Control. 2015;26(11):1685–90. https://doi.org/10.1007/s10552-015-0650-0 CrossRefPubMedGoogle Scholar
- 23.Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016;122(2):312–21. https://doi.org/10.1002/cncr.29734 CrossRefPubMedGoogle Scholar
- 24.Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol. 2010;25(10):1661–7. https://doi.org/10.1111/j.1440-1746.2010.06405.x CrossRefPubMedGoogle Scholar
- 26.Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, et al. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014;38(2):344–9. https://doi.org/10.1016/j.cct.2014.06.006 CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Coronado GD, Sanchez J, Petrik A, Kapka T, DeVoe J, Green B. Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ. 2014;29(1):86–90. https://doi.org/10.1007/s13187-013-0551-4 CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, et al. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches. J Gen Intern Med. 2018;33(1):72–8. https://doi.org/10.1007/s11606-017-4184-x CrossRefPubMedGoogle Scholar
- 29.Coronado GD, Petrik AF, Keast EM, Vollmer WM, Taplin SH, Fields S, et al. Effectiveness of a Pragmatic Direct-Mail Colorectal Cancer Screening Program in Safety Net Clinics. JAMA Int Med. 2018.Google Scholar
- 30.Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, et al. The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016;33(6):639–43. https://doi.org/10.1093/fampra/cmw065 CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Darlington RB, Hayes AF. Regression for Prediction. Regression Analysis and Linear Models: Concepts, Applications, and Implementation 1st ed. New York: Guilford Press; 2016.Google Scholar
- 33.Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290–7. https://doi.org/10.1136/jech.2004.029454 CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41. https://doi.org/10.1001/jamainternmed.2014.2352 CrossRefPubMedGoogle Scholar
- 36.Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, et al. Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test. Gut. 2017. https://doi.org/10.1136/gutjnl-2017-314753
- 37.Knudsen MD, Berstad P, Hjartaker A, Gulichsen EH, Hoff G, de Lange T, et al. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening. Br J Cancer. 2017. https://doi.org/10.1038/bjc.2017.189
- 39.Petrik AF, Le T, Keast E, Rivelli J, Bigler K, Green B, et al. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018;43(1):128–36. https://doi.org/10.1007/s10900-017-0395-7 CrossRefPubMedGoogle Scholar
- 43.Green BB, Wang CY, Anderson ML, Chubak J, Meenan RT, Vernon SW, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013;158(5 Pt 1):301–11. https://doi.org/10.7326/0003-4819-158-5-201303050-00002 CrossRefPubMedPubMedCentralGoogle Scholar